Pregnancy outcome in 162 women with rheumatic diseases: experience of a university hospital in Turkey

• DOI: 10.1007/s00404-017-4535-1
• Publication Date: 2017-09-25T04:11:12Z
• Authors: Ebru Alici Davutoğlu; Aysegul Ozel; Nevin Yılmaz; Riza Madazli
• Keywords: Adult; Fetal Growth Retardation; Turkey; Infant, Newborn; Pregnancy Outcome; Gestational Age; Stillbirth; Delivery, Obstetric; 3. Good health; Hospitals, University; Pregnancy Complications; 03 medical and health sciences; 0302 clinical medicine; Pre-Eclampsia; Pregnancy; Rheumatic Diseases; Birth Weight; Humans; Premature Birth; Female; Retrospective Studies

To evaluate the distribution and the obstetric outcomes of pregnancies with different types of rheumatic diseases managed in our unit.Pregnancies of 162 women with rheumatic diseases, seen for their antenatal care at our department for the period between 2013 and 2017 were included in this retrospective clinical study. Obstetric and perinatal outcomes were main outcome measures.The most encountered rheumatic diseases were SLE (37.7%) followed by Behcet's disease (20.4%) and rheumatoid arthritis (17.3%) in our series. The mean maternal age was 30.6 ± 5.3 and the rate of nulliparity was 38.3% in the overall group. Disease activation occurred in 14.1% of patients. Mean gestational age at delivery was 37.4 ± 3.1 and mean birth weight was 3004 ± 762 g. Stillbirth, neonatal death, fetal growth restriction, preeclampsia and preterm delivery rates were 1.2, 2.4, 17.3, 7.4 and 17.9%, respectively. Antiphospholipid syndrome had the highest incidences for fetal growth restriction (42.9%), preeclampsia (28.6%) and delivery ≤ 34 gestational weeks (42.9%). Pathologic uterine artery Doppler velocimetry was identified in 15 cases (15/162, 9.3%) in which 10 (66.7%) developed preeclampsia and/or fetal growth restriction during follow-up.A majority of women with rheumatic diseases have successful pregnancies and deliver healthy babies, with the close and appropriate rheumatological, obstetric and neonatal monitoring.